In This Section      

Transcatheter Aortic Valve Replacement (TAVR)

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure for patients who need a new aortic valve due to aortic valve stenosis but who are at high risk for open-heart surgery.

appointment icon

Request an Appointment


Treating Structural Heart Disease | FAQ with Drs. Jon Resar and Stefano Schena

Johns Hopkins cardiologist Jon Resar and cardiac surgeon Stefano Schena discuss the Structural Heart Disease Clinic at Johns Hopkins and answer commonly asked questions about transcatheter aortic valve replacement (TAVR) to treat aortic stenosis.

Transcatheter Aortic Valve Replacement (TAVR): What You Need to Know

Get TAVR information from
  • The damaged heart valve is replaced using a valve made of natural tissue obtained from the heart of a pig or cow.
  • The new valve is delivered via catheter, a long, thin tube inserted in an artery and guided to the heart.
  • The catheterization procedure typically takes one to three hours, and patients are up and walking within 24 to 48 hours after the procedure. The typical hospital stay is three to five days.
  • These transcatheter-delivered valves are FDA approved for patients at high risk for conventional open heart surgery.

Patient Resources


Recent News and Articles

Johns Hopkins Collaboration Provides Alternative to Open Heart Surgery for DC Region Patients

woman with doctor

Center for Transcatheter Interventions for Structural Heart Disease

Learn more about the multidisciplinary team — consisting of interventional cardiologists, cardiac surgeons, cardiac imaging experts, nurses and technologists — evaluates, manages, and treats a wide variety of diseases affecting the heart.